Division of Visceral Surgery and Transplantation , University Hospital Zurich
Zurich, 8091, Switzerland
NCT Number: NCT07642791
The knowledge, coupled with epidemiological studies demonstrating lower ovarian cancer rates in women with a history of tubal sterilization has led to recommendations for opportunistic salpingectomy at the time of benign gynecological surgery. However, this recommendation was not explored in the setting of non-gynecological surgeries, of most if the surgery performed not in pelvis.
This study aims to evaluate the safety of performing opportunistic salpingectomy at the time of elective laparoscopic cholecystectomy in women aged 45 years or older. Of note, the only available prospective study from Austria evaluated feasibility of combined operation. By assessing complication rates and other perioperative outcomes, the study seeks to determine if this combined approach is a safe for opportunistic ovarian cancer prevention. Ultimately, this research may inform surgical practice and potentially reduce the incidence of ovarian cancer in this population.
This study is active but is not currently recruiting participants.
Notify Me45 year and older
Female
Interventional
Not applicable
Zurich, 8091, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Opportunistic salpingectomy at the time of elective laparoscopic cholecystectomy will be performed in study group, while the control group undergo cholecystectomy without salpingectomy.
Cholezystectomy as controll group
Time frame: within 6 weeks after surgery
This will be the primary outcome measure, encompassing any complications assessed with Comprehensive Complication Index. The range between 0 and 100. The higher score means more complications.
Time frame: Operating time in minutes during surgical procedure
Operating time measured in minutes from incision until skin stich
Time frame: Length of hospital stay: The number of days patients remain hospitalized after surgery untill discharge assedd at discharge (assessed at around 5 days).
Length of hospital stay calculated in days
University of Zurich
Other
Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05891171
Adenocarcinoma, Adnexal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05467670
Adnexal Diseases, Endocrine Gland Neoplasms
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05787587
Adnexal Diseases, Advanced or Metastatic Solid Tumors
Phoenix, Arizona, United States
View Trial DetailsNCT04830709
Adnexal Diseases, Endocrine Gland Neoplasms
Böblingen, Germany
View Trial Details